Maturational changes in sodium metabolism in periviable infants

Jeffrey L Segar1,2, Connie C Grobe3, Justin L Grobe4,5,6,7,8

  • 1Division of Neonatology, Department of Pediatrics, Medical College of Wisconsin, 999 North 92nd St, Suite C410, Milwaukee, WI, 53226, USA. jsegar@mcw.edu.

Insights

Extremely preterm infants experience prolonged sodium loss and negative balance. Higher sodium intake than currently recommended is necessary for adequate growth in these vulnerable infants.

Area of Science:

  • Neonatalogy
  • Pediatric Nephrology
  • Nutritional Science

Background:

  • Sodium depletion is linked to impaired somatic growth in infants.
  • Sodium requirements for extremely preterm (periviable) infants are not well-established.
  • Understanding early-life sodium homeostasis is critical for this population.

Purpose of the Study:

  • To investigate sodium homeostasis in extremely preterm infants during the first 10 weeks of life.
  • To determine the sodium requirements for achieving positive sodium balance and supporting growth.

Main Methods:

  • Longitudinal, observational study design.
  • Convenience cohort of 23 infants born at 22 0/7-23 6/7-week gestation.
  • Monitoring of sodium intake and urinary sodium excretion.

Main Results:

  • Urinary sodium loss remained high, averaging 7.7 mEq/kg/day at 2 weeks and 6.9 mEq/kg/day at 8 weeks.
  • Positive sodium balance was not achieved until 6 weeks of age.
  • A positive sodium balance associated with significant weight gain (30 g/day) was only observed at 10 weeks.

Conclusions:

  • Infants born at 22-23 weeks gestation exhibit prolonged high urinary sodium losses and negative sodium balance.
  • Current sodium intake recommendations may be insufficient for this population.
  • Increased sodium intake is required to achieve a significant positive sodium balance and support optimal growth.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
49
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
71
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
58
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
1.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68